Bachem Holding AG Bachem Holding AG

Bachem Holding AG

BANB

주식 순위 #2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
주가
$100.60
시가총액
$7.54B
변동 (1일)
-1.49%
변동 (1년)
49.53%
국가
CH
거래 Bachem Holding AG (BANB)

카테고리

Healthcare
Bachem Holding AG (BANB)의 EPS
2026 기준 EPS TTM: 0
Bachem Holding AG의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Bachem Holding AG의 EPS 기록 (2002 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2025 $2.50 40.86%
2024 $1.77 -0.69%
2023 $1.78 20.37%
2022 $1.48 -16.61%
2021 $1.78 42.52%
2020 $1.25 54.63%
2019 $0.81 14.96%
2018 $0.70 10.27%
2017 $0.64 6.14%
2016 $0.60 27.46%
2015 $0.47 8.62%
2014 $0.43 10.38%
2013 $0.39 56.07%
2012 $0.25 68.66%
2011 $0.15 -66.84%
2010 $0.45 -32.70%
2009 $0.67 -18.95%
2008 $0.82 -3.00%
2007 $0.85 45.84%
2006 $0.58 27.75%
2005 $0.46 10.28%
2004 $0.41 -8.68%
2003 $0.45 25.23%
2002 $0.36 0.00%
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$17.32 -
US
$-7.98 -
US
$-5.29 -
AU
$27.74 -
NL
- -
CH